Nanoparticles for personalised cancer vaccines: results in mice
Science & technology · 30 October 2026
MIT researchers have developed an M13 bacteriophage platform with adjustable antigen density. In mouse experiments, higher-density vaccines improved protection against tumour development. These are preclinical findings, not evidence of effectiveness in people.
Source: Anne Trafton · MIT News.